The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ELEPHAS-01, ELEPHAS-02 and ELEPHAS-04: Multi-institutional observational prospective clinical trials to assess the accuracy of an ex vivo live tumor fragment platform for predicting immunotherapy response.
 
Hinco Gierman
Employment - Elephas Bio; Illumina; IntegraConnect
Leadership - Elephas Bio
Stock and Other Ownership Interests - Elephas Bio; Illumina; IntegraConnect
Consulting or Advisory Role - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Patent title: Systems and methods for outlier significance assessment Patent date Filed: Nov 3, 2016 IP-1417-PRV
Travel, Accommodations, Expenses - Bristol-Myers Squibb
(OPTIONAL) Uncompensated Relationships - Panacea Pharmaceuticals
 
Hilary Hernan
Employment - Elephas
 
Veronica (Ming) Wang
Employment - Elephas Bio
Stock and Other Ownership Interests - Lilly; Stryker; Tempus; Vertex
 
Catarina Costa
Employment - Elephas Bio
Stock and Other Ownership Interests - Elephas Bio
Travel, Accommodations, Expenses - Elephas Bio
 
Jackie Derrick
Employment - Elephas
 
Rebecca Tarlazzi
No Relationships to Disclose
 
Ann Leonard
Employment - Elephas Bio
 
Michael Korrer
No Relationships to Disclose
 
Laura Hrycyniak
Employment - Elephas Biosciences Corp
Travel, Accommodations, Expenses - Elephas Biosciences Corp
 
Sean Caenepeel
No Relationships to Disclose
 
Tarun Chandra
Consulting or Advisory Role - Abbott Laboratories; Caris Life Sciences (Inst); Nucleix (Inst); Promega; Sysmex; Thermo Fisher Scientific
 
Timothy Ziemlewicz
Stock and Other Ownership Interests - Histosonics
Consulting or Advisory Role - Elephas Bio; Histosonics
Research Funding - Ethicon/Johnson & Johnson; Histosonics
 
Sam Lubner
Stock and Other Ownership Interests - Elephas Bio
Consulting or Advisory Role - Elephas Bio
Research Funding - Agios (Inst); AstraZeneca/MedImmune/Spirogen (Inst); Bristol Myers Squibb Foundation (Inst); Incyte (Inst)
 
Nima Kokabi
Honoraria - Boston Scientific; Okami Medical; Sirtex Medical
Consulting or Advisory Role - Boston Scientific; Galvanize Therapeutics; Okami Medical; Sirtex Medical; TERUMO
Speakers' Bureau - Boston Scientific; Okami Medical; Sirtex Medical
Research Funding - Okami Medical; Sirtex Medical
Travel, Accommodations, Expenses - Boston Scientific; Okami Medical; Sirtex Medical
 
Giuseppe Toia
Consulting or Advisory Role - Canon Medical System
 
Debabrata Mukhopadhyay
Employment - Sagittrax LLC as Founder and CEO
Leadership - Sagittrax LLC as Founder and CEO
Stock and Other Ownership Interests - Sagittrax LLC as Founder and CEO
Research Funding - Elephas
 
Pooja Advani
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I); AstraZeneca (Inst); Epic Sciences; Epic Sciences; GE Healthcare; Menarini Group; OncLive/MJH Life Sciences
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); AstraZeneca (Inst); BMS (I); Breathe BioMedical; Puma Biotechnology
Speakers' Bureau - AstraZeneca (Inst); GE hea; Menarini
Research Funding - Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); biovica (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); Seagan (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)